Longevity & AgingResearch PaperOpen Access

Three Days of Partial Reprogramming Lets Skin Cells Become Neurons With a Single Factor

Just 3 days of transient reprogramming lets human fibroblasts turn into neurons using NGN2 alone, cutting the time to a human neuron model to about 12 days.

Saturday, November 14, 2026 0 views
Published in J Mol Neurosci
Fibroblast cells morphing into glowing branching neurons inside a microfluidic chip channel, fluorescent green and red staining

Summary

Making human neurons from skin cells usually takes weeks, either through slow direct conversion with several factors or through a lengthy detour via stabilized induced pluripotent stem cells (hiPSCs). This study shows that a brief burst of reprogramming factors makes human fibroblasts responsive to a single neuronal factor, NGN2. Using microfluidic mRNA reprogramming and single-cell RNA sequencing, the authors characterized early intermediate cell states that arise by days 3-5. Cells exposed to only 3 or 5 days of reprogramming converted into neurons after NGN2 induction, whereas untreated fibroblasts did not. Conversion was more efficient from later intermediates. The resulting neurons expressed mature and glutamatergic synaptic markers. The approach could shorten timelines for patient-specific neuron models, though functional and in vivo validation are still needed.

Detailed Summary

Human neuronal models are central to studying neurological disease and screening drugs, but making them is slow. Direct conversion of fibroblasts to neurons takes 3-6 weeks, has low efficiency, and usually needs several transcription factors. Going through hiPSCs is more efficient but adds weeks to stabilize the lines, varies between cell lines, and risks leaving residual pluripotent cells.

The authors tested whether partial reprogramming could bridge these approaches. They reprogrammed BJ human foreskin fibroblasts in a microfluidic device with daily non-modified mRNA transfections (POU5F1, SOX2, KLF4, MYC, LIN28, NANOG). They revisited single-cell RNA-seq data from days 0, 3, 5 and 11. Cells were then transduced with doxycycline-inducible NGN2 lentiviruses and moved to neural induction medium for 9 days.

The single-cell data showed that fibroblast markers (ANPEP, SERPINE1, MMP1, SNAI2) fell by day 5 while epithelial markers (KRT8, KRT18) rose, consistent with a mesenchymal-to-epithelial transition. Early pluripotency-associated genes (PODXL, B3GALT5) appeared in a day 5 cluster, whereas canonical markers (POU5F1, NANOG) were largely restricted to day 11. Three early somatic-related intermediate populations were responsive to NGN2.

NGN2 alone did not convert unreprogrammed fibroblasts, which kept VIMENTIN and fibroblast morphology. Day 11 cultures converted into TUJ1+ neurons, with about 43% of cells NGN2+ two days after induction. From day 5 intermediates, conversion efficiency was about 36% of total cells and about 64% of initially seeded cells at day 14. From day 3 intermediates, it was about 33% of seeded cells at day 12, with no pluripotent colonies remaining. Neurons expressed NEUN, MAP2, and co-localized VGLUT1 and PSD-95, suggesting glutamatergic synapses. Efficiency rose with reprogramming stage.

The approach could deliver patient-specific neurons in about 12 days with one neuronal factor and without a stabilized hiPSC stage, which would help disease modeling and screening. It may also lower tumorigenicity concerns because day 3 intermediates did not form pluripotent colonies.

Caveats: the work used a single fibroblast line, immunostaining-based readouts, and a microfluidic platform that may be hard to scale. Electrophysiology was not shown in the available text, and rejuvenation or aging-related features were not tested. Some NANOG+ colonies persisted in day 5 and day 11 cultures.

Key Findings

  • Only 3 days of mRNA reprogramming made human fibroblasts competent for NGN2-driven neuronal conversion, whereas unreprogrammed fibroblasts failed to convert.
  • Single-cell RNA-seq identified three early somatic-related intermediate populations (SR2-5) undergoing MET with partial pluripotency gene activation.
  • Day 5 intermediates yielded about 64% neuronal conversion of seeded cells; day 3 intermediates yielded about 33% with no pluripotent colonies.
  • Resulting neurons expressed TUJ1, NEUN, MAP2, and co-localized VGLUT1/PSD-95, consistent with glutamatergic synapse formation.
  • Neuronal conversion efficiency increased with reprogramming progression, so the starting stage strongly determines NGN2 responsiveness.

Methodology

BJ human fibroblasts were reprogrammed in PDMS microfluidic chambers using 3, 5, or 8 daily mRNA transfections, and previously generated scRNA-seq data (days 0, 3, 5, 11) defined intermediate clusters. Cells were transduced with doxycycline-inducible NGN2 lentiviruses and cultured for 9 days in neural induction medium, with BDNF/NT3 added for the last 4 days. Outcomes were assessed by immunofluorescence, with controls lacking doxycycline or prior reprogramming.

Study Limitations

Only one fibroblast line (fetal-derived foreskin BJ cells) and one neuronal subtype (glutamatergic) were tested, and the available text provides no electrophysiological data or comparisons across donors or ages. Conversion relied on lentiviral transduction and microfluidic devices, which limit scalability, and some residual pluripotent colonies persisted in later-stage starts. Efficiency figures show substantial variability.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: